Scott Boitano Selected Research

3- (4- Amino- 5- cyclopropylpyrimidine- 2- yl)- 1- (2- fluorobenzyl)- 1H- pyrazolo(3,4- b)pyridine

9/2011

Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott Boitano Research Topics

Disease

8	Pain (Aches) 11/2023 - 05/2011
7	Asthma (Bronchial Asthma) 01/2023 - 04/2011
6	Inflammation (Inflammations) 01/2023 - 12/2018
5	Hypersensitivity (Allergy) 04/2023 - 05/2015
4	Respiratory Hypersensitivity 01/2023 - 12/2021
4	Wounds and Injuries (Trauma) 03/2013 - 08/2006
3	Chronic Pain 01/2017 - 05/2015
2	Neoplasms (Cancer) 11/2023 - 05/2015
2	Migraine Disorders (Migraine) 04/2023 - 01/2019
2	Hyperplasia 01/2022 - 12/2018
2	Eosinophilia 12/2021 - 01/2019
2	Lung Injury 09/2009 - 03/2008
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2023
1	Headache (Headaches) 04/2023
1	Visceral Pain 01/2020
1	Hyperalgesia 01/2019
1	Peripheral Nerve Injuries 01/2017
1	Cold Hypersensitivity 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2013
1	Infections 01/2013
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2013
1	Hypertension (High Blood Pressure) 09/2011
1	Lung Diseases (Lung Disease) 05/2011
1	Pneumonia (Pneumonitis) 04/2011
1	Burns 09/2009

Drug/Important Bio-Agent (IBA)

9	Peptide Hydrolases (Proteases)FDA Link 04/2023 - 08/2008
4	PAR-2 ReceptorIBA 11/2023 - 05/2015
4	AllergensIBA 01/2023 - 04/2011
4	ArsenicIBA 03/2013 - 08/2008
3	ArrestinIBA 01/2023 - 12/2018
3	Proteinase-Activated ReceptorsIBA 01/2023 - 05/2015
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2023 - 12/2021
2	CarrageenanIBA 01/2023 - 01/2017
2	TrypsinIBA 01/2022 - 12/2018
2	PeptidomimeticsIBA 01/2022 - 05/2011
2	Serine Proteases (Serine Protease)IBA 12/2018 - 04/2011
2	Phosphotransferases (Kinase)IBA 01/2017 - 05/2015
2	arseniteIBA 03/2013 - 05/2011
2	Adenosine Triphosphate (ATP)IBA 03/2013 - 05/2011
2	SmokeIBA 09/2009 - 03/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2023
1	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2023
1	Leukocyte Elastase (Neutrophil Elastase)IBA 04/2023
1	Vasodilator Agents (Vasodilators)IBA 04/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	Differentiation AntigensIBA 12/2021
1	OvalbuminIBA 12/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Surface-Active Agents (Surfactants)IBA 01/2019
1	p-Methoxy-N-methylphenethylamineIBA 01/2019
1	MucinsIBA 12/2018
1	Serine (L-Serine)FDA Link 12/2018
1	beta-Arrestin 1IBA 12/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2018
1	protease SIBA 12/2018
1	cercosporamideIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	Nerve Growth Factor (NGF)IBA 01/2017
1	RNA Cap-Binding Proteins (Cap Binding Protein)IBA 01/2017
1	Eukaryotic Initiation Factor-4EIBA 01/2017
1	Eukaryotic Initiation Factor-4F (EIF4F)IBA 05/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2015
1	PKC-3 proteinIBA 05/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2015
1	TropomyosinIBA 05/2015
1	Peptide Initiation Factors (Initiation Factor)IBA 05/2015
1	U 0126 (UO 126)IBA 05/2015
1	Dinoprostone (PGE2)FDA Link 05/2015
1	3- (4- Amino- 5- cyclopropylpyrimidine- 2- yl)- 1- (2- fluorobenzyl)- 1H- pyrazolo(3,4- b)pyridineIBA 09/2011
1	SaltsIBA 05/2011
1	Protease Inhibitors (Protease Inhibitor)IBA 09/2009
1	Drinking WaterIBA 08/2008
1	Matrix Metalloproteinases (MMPs)IBA 08/2008
1	Extracellular Matrix ProteinsIBA 08/2006

Therapy/Procedure

3	Therapeutics 11/2023 - 01/2023
1	Drug Therapy (Chemotherapy) 11/2023
1	Intraperitoneal Injections 04/2023
1	Sutures (Suture) 04/2023
1	Intranasal Administration 12/2018
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 09/2009